The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
So far 70 confirmed human cases of H5N1 infection have been reported, following a widespread outbreak across bird and cattle ...
The previously-unknown condition, dubbed 'post-vaccination syndrome' (PVS), can persist years after taking the Covid vaccines ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
The funding review is part of a broader government push to examine spending on messenger RNA-based vaccines, the technology that Moderna and Pfizer used to develop their COVID-19 vaccines.